October 25 2010  |  News Article 


New brachytherapy solutions for prostate cancer focus on five positive aspects for both patients and clinics 

Veenendaal, The Netherlands (25 October 2010) Nucletron, a leading provider of state of the art radiotherapy solutions for cancer treatment recently launched the campaign ‘Count your Blessings’ following the presentation of a new integrated solution for brachytherapy for treating prostate cancer. The advanced solution tackles the disease while minimizing damage to the healthy surrounding tissue, delivering on both cure, quality of life after treatment and cost containment.

Compared to other forms of radiotherapy like external beam (EBRT), brachytherapy delivers the required dose of radiation over a significantly shortened treatment time. In treating prostate cancer, normal treatment times that can take up to seven weeks with EBRT take only one or two days with brachytherapy. Additionally, the precise delivery of radiation reduces the risk of unnecessary damage to surrounding healthy tissue and organs which can help reduce side effects. Also, the risk of side effects like incontinence and erectile dysfunction is lower after brachytherapy than after prostatectomy, for example. These factors minimise disruption to patients and allow a faster return to everyday life.

Nucletron prostate solutions is the first complete programme for prostate brachytherapy. Available for two treatment types, -permanent Low Dose Rate (LDR) seeds implantation and High Dose Rate (HDR)- it offers the best choice of treatment for many prostate cancer patients. Each solution integrates the latest state-of-the-art Oncentra treatment planning software with best-in-class brachytherapy equipment. The result is a dual system to offer cancer patients the positive benefits of prostate brachytherapy.

Count your blessings with Nucletron’s Prostate Positive 5:
1. Clinical effectiveness
2. Urinary function
3. Sexual function
4. Treatment and recovery times
5. Costs


Nucletron Prostate Seeds
Seeds brachytherapy enjoys wide acceptance thanks to its minimally invasive nature and excellent treatment results. A key factor for favourable clinical outcomes is the quality of the radiation dose plan and seeds delivery. Nucletron Prostate Seeds is a best-in-class brachytherapy system that integrates the latest advancements in Oncentra Seeds treatment planning with the seedSelectron’s unique robotic implant technology - a system that considerably reduces the manual dependency risk, resulting in superior treatment outcomes.

Nucletron Prostate HDR
HDR brachytherapy is also a widely accepted, minimally invasive procedure with excellent clinical outcomes. The Nucletron Prostate HDR solution integrates best-in-class Oncentra Prostate treatment planning with high precision afterloading. It offers faster, more accurate treatment, higher patient throughput for a clinic, greater comfort for your patients and excellent flexibility within your real-time workflow. Integrating Nucletron Prostate HDR into treatment capabilities means being confident of having the best HDR prostate solution available today.

To find out more about Nucletron’s prostate solutions, visit http://www.prostatepositive5.com/ and Count your Blessings.

About Brachytherapy
Brachytherapy is a high-precision radiation therapy, in which the radiation source used to kill cancer cells and shrink tumors is placed in or close to the tumor itself. Brachytherapy offers a precise, highly effective and well tolerated treatment option tailored to the needs of individual patients. The precision brachytherapy approach allows a physician to concentrate a high dose of radiation in a small area, minimizing damage to nearby, healthy body tissue and organs, over a shorter treatment period. Find more about brachytherapy on http://www.aboutbrachytherapy.com/.
For further information:
Nucletron
Mark van Braak
Marketing Communications Manager
Email: mark.vanbraak@nl.nucletron.com
Tel: +31 (0) 318 557 255